International Journal of Hematology and Oncology 2022, Vol 32, Num 4 Page(s): 224-226
Evaluation of Efficacy and Safety of Ponatinib as Third-line Treatment in Patients with the Diagnosis of Chronic Phase Chronic Myeloid Leukemia

Pusem PATIR1, Nur SOYER1, Filiz VURAL1, Guray SAYDAM1

Ege University Faculty of Medicine, Department of Hematology, Izmir, TURKEY